Bulk Inquiry
AZD3759
- Zorifertinib
- Optical Purity: Optically pure
- Soluble in 0.1N HCl(aq) and DMSO
- MF: C22H23ClFN5O3
- MW: 459.9
Description
AZD3759 (Zorifertinib) is a potent, orally active and brain-penetrant EGFR tyrosine kinase inhibitor designed to inhibit mutant EGFR signaling in central nervous system disease models. It suppresses EGFR phosphorylation in L858R-mutant cellular systems.
EGFR signaling drives proliferation and survival in subsets of non-small cell lung cancer, including tumors with CNS metastases. AZD3759 is useful for studying brain-penetrant EGFR inhibition and intracranial tumor pharmacology.
Key Features
- Brain-penetrant EGFR tyrosine kinase inhibitor
- Reported IC50: 7.2 nM for inhibition of cellular EGFR phosphorylation in L858R models
- Orally active pharmacology
- Designed for CNS metastasis-relevant EGFR signaling studies
Applications
- EGFR kinase pharmacology
- NSCLC and EGFR-mutant cancer models
- Brain metastasis and CNS penetration studies
- Phospho-EGFR pathway assays
More Information
| Parent CAS No. | 1626387-80-1 |
|---|---|
| Chemical Name | (R)-4-(3-chloro-2-fluorophenylamino)-7-methoxyquinazolin-6-yl 2,4-dimethylpiperazine-1-carboxylate |
| SMILES | N1(C(OC2C(OC)=CC3C(C=2)=C(NC2=CC=CC(Cl)=C2F)N=CN=3)=O)CCN(C)C[C@H]1C |&1:30,r| |
| MFCD | N.A. |
| InChi | InChI=1S/C22H23ClFN5O3/c1-13-11-28(2)7-8-29(13)22(30)32-19-9-14-17(10-18(19)31-3)25-12-26-21(14)27-16-6-4-5-15(23)20(16)24/h4-6,9-10,12-13H,7-8,11H2,1-3H3,(H,25,26,27)/t13-/m1/s1 |
| InChiKey | MXDSJQHFFDGFDK-CYBMUJFWSA-N |
| CID | 78209992 |
| Short Description | EGFR inhibitor |
Related Products
| AXON ID | NAME | FROM PRICE |
|---|---|---|
| 1128 | Erlotinib hydrochloride |
From $77.00 |
| 1393 | Gefitinib |
From $77.00 |
| 1395 | Lapatinib ditosylate |
From $88.00 |
| 1411 | Vandetanib |
From $55.00 |
| 1433 | CI 1033 |
From $66.00 |
| 1506 | WZ 4002 |
From $77.00 |
| 1526 | Neratinib |
From $88.00 |
| 1544 | BIBW 2992 |
From $55.00 |
| 1632 | OSI 420 |
From $99.00 |
| 1653 | AEE 788 |
From $88.00 |
| 1665 | Pelitinib |
From $99.00 |
| 1760 | EGFR Inhibitor [879127-07-8] |
From $132.00 |
| 1986 | AST 1306 tosylate |
From $99.00 |
| 2342 | AZD9291 |
From $104.50 |
| 2680 | EAI045 |
From $115.50 |
| 2920 | Poziotinib |
From $104.50 |
| 2955 | NSC 228155 |
From $82.50 |
| 3040 | Abivertinib |
From $104.50 |
| 3192 | EMI48 |
From $132.00 |
| 3232 | TAK-788 |
From $77.00 |
| 3235 | Dacomitinib |
From $66.00 |
| 3802 | TAS6417 |
From Inquiry |
| 3853 | BMS-599626 |
From Inquiry |
| 3862 | BGB-283 |
From Inquiry |
